|
End-of-day quote
Shenzhen S.E.
30/09/2026
|
5-day change | 1st Jan Change | ||
| 33.27 CNY | +2.06% |
|
+2.06% | -0.83% |
| 04/09 | ApicHope Pharmaceutical Obtains Approval for Sertraline Oral Solution in China | MT |
| 04/09 | ApicHope Pharmaceutical's Gout Drug Meets Primary Endpoint in Drug Trial | MT |
| Market Cap | 1.49TCr 222.57Cr 198.86Cr 185.53Cr 168.52Cr 317.39Cr 22TCr 319.76Cr 2.23TCr 871.03Cr 11TCr 835.56Cr 817.49Cr 35TCr | P/E 2026 * |
28.7x | P/E 2027 * | -145x |
|---|---|---|---|---|---|
| Enterprise Value | 1.49TCr 222.57Cr 198.86Cr 185.53Cr 168.52Cr 317.39Cr 22TCr 319.76Cr 2.23TCr 871.03Cr 11TCr 835.56Cr 817.49Cr 35TCr | EV / Sales 2026 * |
13.8x | EV / Sales 2027 * | 11.9x |
| Free-Float |
31.84% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +2.06% | ||
| 1 week | +2.06% | ||
| 1 month | -6.52% | ||
| 3 months | -17.85% | ||
| 6 months | -8.95% | ||
| Current year | -0.83% |
| 1 month | 32.2 |  | 35.96 |
| Current year | 29.31 | | 45.88 |
| 1 year | 29.31 | | 62.5 |
| 3 years | 12.74 | | 81.48 |
| 5 years | 12.74 | | 81.48 |
| 10 years | 7.58 | | 81.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Han Xiong Li
CEO | Chief Executive Officer | 52 | 11/11/2015 |
Hui Xing Zhang
DFI | Director of Finance/CFO | 60 | 11/11/2015 |
Xiao Dong Liu
IRC | Investor Relations Contact | 38 | 31/12/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Han Xiong Li
CHM | Chairman | 52 | 11/11/2015 |
Han Dong Li
BRD | Director/Board Member | 58 | 11/11/2015 |
Liang Wen Huang
CHM | Chairman | 50 | 11/11/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 05/01/26 | Buy | Director | 4,200 | 0.0010% | ||
| 24/11/25 | Buy | Director | 7,000 | 0.0017% | ||
| 01/09/23 | Buy | 20,000 | 0.0089% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.06% | +2.06% | -44.02% | +29.76% | 222.57Cr | |
| -3.93% | -1.42% | +34.02% | +98.24% | 1,06000Cr | |
| -2.24% | -2.27% | +33.26% | +59.45% | 62TCr | |
| -1.47% | +2.80% | +15.55% | +79.20% | 48TCr | |
| -2.38% | -3.07% | +61.33% | +33.39% | 35TCr | |
| -1.74% | +1.49% | +21.59% | +41.20% | 35TCr | |
| -2.17% | -0.47% | +10.33% | +33.33% | 27TCr | |
| -2.14% | -3.00% | -6.79% | +9.73% | 25TCr | |
| -2.73% | -1.57% | +36.06% | +47.63% | 22TCr | |
| -1.08% | -1.93% | +22.33% | +92.73% | 18TCr | |
| Average | -1.73% | -0.76% | +18.37% | +52.46% | 37.9TCr | |
| Weighted average by Cap. | -2.45% | +0.04% | +28.08% | +64.43% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 108Cr 16Cr 14Cr 13Cr 12Cr 23Cr 1.56TCr 23Cr 161.36Cr 63Cr 792.46Cr 60Cr 59Cr 2.55TCr | 125.8Cr 19Cr 17Cr 16Cr 14Cr 27Cr 1.82TCr 27Cr 187.95Cr 73Cr 923.07Cr 70Cr 69Cr 2.97TCr |
| Net income | 53Cr 7.85Cr 7.01Cr 6.54Cr 5.94Cr 11Cr 758.9Cr 11Cr 79Cr 31Cr 385.96Cr 29Cr 29Cr 1.24TCr | -10Cr -1.52Cr -1.36Cr -1.27Cr -1.15Cr -2.17Cr -147.16Cr -2.19Cr -15Cr -5.95Cr -75Cr -5.71Cr -5.59Cr -240.6Cr |
| Net Debt | - | - |
Employees
1,294
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/26/08 | CN¥32.84 | -1.29% | 36,74,470 |
| 30/26/30 | CN¥33.27 | +2.06% | 43,99,720 |
| 29/26/29 | CN¥32.60 | +0.31% | 28,90,200 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300723 Stock
Select your edition
All financial news and data tailored to specific country editions
